Naloxone 400mcg Injection Franchise in Ahmedabad

Opioid Antidote Injection Supplier in Mumbai

Naloxyn Injection Distributor in Delhi

Emergency Opioid Treatment Injection Franchise Opportunity in Bangalore

Hospital Injectable Antidote Stockist in Hyderabad
Naloxone 400mcg Export & Manufacturing in Chandigarh

Home/Products /naloxone-400mcg-injection

Naloxyn Injection

Composition : Naloxone (400mcg) Injection

Dosage Form : Injection

Packaging Type : Ampule

Packaging : 5x1ml

Price : ₹1/-

Naloxyn Injection contains Naloxone 400mcg, a potent opioid antagonist indicated for the emergency treatment of opioid overdose and the reversal of opioid-induced respiratory depression. It helps in rapid restoration of normal respiration and alertness in affected patients.

Naloxone works by competitively binding to opioid receptors in the central nervous system, effectively reversing the effects of opioids and restoring vital physiological functions. Its fast onset of action makes it indispensable in emergency and critical care settings.

For distributors and healthcare suppliers, Naloxyn Injection is a high-priority emergency medicine, widely supplied to hospitals, emergency care centers, and ambulatory services. Protocol-based usage ensures consistent demand in institutional healthcare setups.

Adding Naloxyn Injection to your opioid antidote and emergency therapy segment creates strong opportunities in hospitals, critical care units, emergency pharmacies, export markets, and third-party manufacturing. Its essential therapeutic role, life-saving action, and strong prescriber confidence make it a critical product in pharmaceutical distribution portfolios.

Read More

About the Product

Naloxyn Injection contains Naloxone 400mcg, a potent opioid antagonist indicated for the emergency treatment of opioid overdose and the reversal of opioid-induced respiratory depression. It helps in rapid restoration of normal respiration and alertness in affected patients.

Naloxone works by competitively binding to opioid receptors in the central nervous system, effectively reversing the effects of opioids and restoring vital physiological functions. Its fast onset of action makes it indispensable in emergency and critical care settings.

For distributors and healthcare suppliers, Naloxyn Injection is a high-priority emergency medicine, widely supplied to hospitals, emergency care centers, and ambulatory services. Protocol-based usage ensures consistent demand in institutional healthcare setups.

Adding Naloxyn Injection to your opioid antidote and emergency therapy segment creates strong opportunities in hospitals, critical care units, emergency pharmacies, export markets, and third-party manufacturing. Its essential therapeutic role, life-saving action, and strong prescriber confidence make it a critical product in pharmaceutical distribution portfolios.

Common side effects may include nausea, vomiting, sweating, tremors, increased heart rate, or mild hypertension. Rare but serious side effects include acute withdrawal symptoms in opioid-dependent patients, severe hypertension, arrhythmias, or pulmonary edema. Close monitoring is required during administration.

Naloxyn Injection is indicated for the emergency treatment of known or suspected opioid overdose, including respiratory depression and severe sedation. It is also used to reverse opioid effects during anesthesia or in neonates born to opioid-dependent mothers.

Naloxyn Injection should be administered only under medical supervision. Patients with a history of cardiovascular disease or those who are opioid-dependent should be carefully monitored. Repeat dosing may be necessary, and supportive measures should be available to maintain airway and breathing.

Store Naloxyn Injection in a cool, dry place, protected from light. Keep out of reach of children. Do not use the injection beyond the expiry date or if the solution appears discolored or contains particles.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation